InBrain: Graphene BCI Therapeutics Strategy
InBrain CEO Carolina Aguilar outlines a strategic pivot from assistive to therapeutic Brain-Computer Interfaces using graphene. The company leverages AI and robotics to address neurological diseases, aiming for mass-market scalability through partnerships with Merck and Microsoft.